4.6 Article

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

breast cancer, early stage

T. S. K. Mok et al.

ANNALS OF ONCOLOGY (2012)

Review Oncology

Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions

Peter M. Ellis et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)

Article Oncology

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors

Brian I. Rini et al.

CLINICAL CANCER RESEARCH (2011)

Review Physiology

NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES

Shom Goel et al.

PHYSIOLOGICAL REVIEWS (2011)

Article Medicine, General & Internal

Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer

Eunice L. Kwak et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement

Ying C. Henderson et al.

CLINICAL CANCER RESEARCH (2008)

Article Medicine, General & Internal

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Alan Sandler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

JH Schiller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)